• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The in-vitro comparative activity of quinolones against bacteria from urinary tract infections in general practice.

作者信息

Willems F T, Boerema J B, von Summeren T R

出版信息

J Antimicrob Chemother. 1986 Jan;17(1):69-73. doi: 10.1093/jac/17.1.69.

DOI:10.1093/jac/17.1.69
PMID:2936709
Abstract

In a study of lower urinary tract infection in general practice over twelve hundred strains have been isolated. Eight hundred and sixty-six consecutive strains were tested against four quinolone compounds. Sixty-nine per cent of the isolates were Escherichia coli and 15% coagulase-negative staphylococci (mostly Staphylococcus saprophyticus). The diffusion method, according to I.C.S. recommendation, was used and standardized for extrapolation of MIC results. Ciprofloxacin followed by norfloxacin and pefloxacin, was the most active quinolone compound (MIC 0 X 015-2 mg/l) against all strains, including multiresistant ones.

摘要

相似文献

1
The in-vitro comparative activity of quinolones against bacteria from urinary tract infections in general practice.
J Antimicrob Chemother. 1986 Jan;17(1):69-73. doi: 10.1093/jac/17.1.69.
2
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].[1989年抗微生物剂对从尿路感染分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 1995 Sep;48(9):1131-60.
3
In-vitro activity of pefloxacin compared with six other quinolones.
J Antimicrob Chemother. 1985 Oct;16(4):485-90. doi: 10.1093/jac/16.4.485.
4
Activity of pefloxacin and thirteen other antimicrobial agents in vitro against isolates from hospital and genitourinary infections.培氟沙星及其他13种抗菌药物对医院感染和泌尿生殖系统感染分离菌株的体外活性。
J Antimicrob Chemother. 1986 Jun;17(6):739-46. doi: 10.1093/jac/17.6.739.
5
In-vitro activity of newer quinolones against aerobic bacteria.新型喹诺酮类药物对需氧菌的体外活性
J Antimicrob Chemother. 1986 Apr;17 Suppl B:29-39. doi: 10.1093/jac/17.suppl_b.29.
6
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.八种新型喹诺酮类药物与萘啶酸的体外活性比较
J Antimicrob Chemother. 1986 Nov;18 Suppl D:1-20. doi: 10.1093/jac/18.supplement_d.1.
7
The comparative in-vitro activity of pefloxacin.培氟沙星的体外比较活性。
J Antimicrob Chemother. 1986 Apr;17 Suppl B:1-10. doi: 10.1093/jac/17.suppl_b.1.
8
Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.单次口服800毫克剂量后,培氟沙星与诺氟沙星对健康女性志愿者尿液的杀菌活性比较。
Infection. 1997 Mar-Apr;25(2):121-6. doi: 10.1007/BF02113592.
9
[Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].培氟沙星(1589 RB)、萘啶酸和氟甲喹抗菌活性的比较(作者译)
Pathol Biol (Paris). 1982 Jun;30(6):394-7.
10
Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.新型氟喹诺酮类药物E-3846在体外以及大鼠实验性膀胱炎和肾盂肾炎中的活性
Antimicrob Agents Chemother. 1988 May;32(5):636-41. doi: 10.1128/AAC.32.5.636.

引用本文的文献

1
Staphylococcus saprophyticus urinary tract infections: epidemiological data from Western Australia.腐生葡萄球菌尿路感染:来自西澳大利亚的流行病学数据。
Eur J Epidemiol. 1996 Feb;12(1):51-4. doi: 10.1007/BF00144428.
2
New 4-quinolones in the treatment of urinary tract infections.
Pharm Weekbl Sci. 1986 Feb 21;8(1):46-52. doi: 10.1007/BF01975480.
3
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
4
Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.培氟沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 May;37(5):628-68. doi: 10.2165/00003495-198937050-00003.